We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email :PharmaSources@imsinoexpo.com
Whatsapp :+86-13621645194
Anti-Cataract Agent Pirenoxine(Catalin, PRX) CAS 1043-21-6
Category:Active Pharmaceutical Ingredients > Other Active Pharmaceutical Ingredients Product Name:Anti-Cataract Agent Pirenoxine(Catalin, PRX) CAS 1043-21-6 CAS No.:1043-21-6 Standard:In-house Standards Price(USD):0.00 Company:TAIZHOU VOLSEN CHEMICAL CO.,LTD.
Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Africa
Sample Provided: no
The highly advanced and precisely formulated Pirenoxine CAS 1043-21-6 we offer our customers are of popular brands known for consistently high quality. Pirenoxine CAS NO 1043-21-6 is also called Catalin and PRX that is widely used to anti-cataract. The mechanism of action of it is interacting with calcium and selenite ions to keep the eye lens, and to keep the vision clear. We can offer best service and effective delivery.
Usage: Catalin (Pirenoxine) CAS 1043-21-6 is an anti-cataract agent used to inhibit the development of cataracts in patients considered at risk. Its mechanism of action is interacting with calcium and selenite ions, which are known to play a central role in the formation of lens cataracts. This in turn can help stop crystals in the eye that are water soluble from insolubilization, which allows for the eye lens and vision to remain clear. Another medical study showed that it might be effective in helping preventing an oxidative attack on the eye lens, which could further explain its potential as a treatment for cataract prevention